Literature DB >> 26994407

Utility of the revised cardiac risk index for predicting postsurgical morbidity in Hb SC and Hb Sβ+-thalassemia sickle cell disease.

Ari Rosenberg1, Vladimir Selounski1, Hamid Wardak2, Jin Han2,3, Michel Gowhari2, Joharah Hassan2, Shivi Jain2, Robert E Molokie2,4, Victor R Gordeuk2, Santosh L Saraf2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26994407      PMCID： PMC5377925          DOI： 10.1002/ajh.24363

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.

Authors:  T H Lee; E R Marcantonio; C M Mangione; E J Thomas; C A Polanczyk; E F Cook; D J Sugarbaker; M C Donaldson; R Poss; K K Ho; L E Ludwig; A Pedan; L Goldman
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

2.  Revised cardiac risk index and postoperative morbidity after elective orthopaedic surgery: a prospective cohort study.

Authors:  G L Ackland; S Harris; Y Ziabari; M Grocott; M Mythen
Journal:  Br J Anaesth       Date:  2010-09-28       Impact factor: 9.166

3.  The Postoperative Morbidity Survey was validated and used to describe morbidity after major surgery.

Authors:  M P W Grocott; J P Browne; J Van der Meulen; C Matejowsky; M Mutch; M A Hamilton; D Z H Levett; M Emberton; F S Haddad; M G Mythen
Journal:  J Clin Epidemiol       Date:  2007-05-07       Impact factor: 6.437

4.  Genetic polymorphism of APOB is associated with diabetes mellitus in sickle cell disease.

Authors:  Xu Zhang; Wei Zhang; Santosh L Saraf; Mehdi Nouraie; Jin Han; Michel Gowhari; Johara Hassan; Galina Miasnikova; Adelina Sergueeva; Sergei Nekhai; Rick Kittles; Roberto F Machado; Joe G N Garcia; Mark T Gladwin; Martin H Steinberg; Paola Sebastiani; Donald A McClain; Victor R Gordeuk
Journal:  Hum Genet       Date:  2015-05-30       Impact factor: 4.132

5.  Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases.

Authors:  M Koshy; S J Weiner; S T Miller; L A Sleeper; E Vichinsky; A K Brown; Y Khakoo; T R Kinney
Journal:  Blood       Date:  1995-11-15       Impact factor: 22.113

6.  The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial.

Authors:  Jo Howard; Moira Malfroy; Charlotte Llewelyn; Louise Choo; Renate Hodge; Tony Johnson; Shilpi Purohit; David C Rees; Louise Tillyer; Isabeau Walker; Karin Fijnvandraat; Melanie Kirby-Allen; Eldon Spackman; Sally C Davies; Lorna M Williamson
Journal:  Lancet       Date:  2013-01-23       Impact factor: 79.321
  6 in total
  1 in total

Review 1.  The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.

Authors:  Lisette M Vernooij; Wilton A van Klei; Karel Gm Moons; Toshihiko Takada; Judith van Waes; Johanna Aag Damen
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.